Saturday, January 09, 2021 2:31:32 AM
Manufacturing and Supplying Adaptogens
MINDCURE seeks to commercialize the therapeutic potential of nootropics, psychoactive products, and psychedelic substances that promote productivity and enhance mental health.
The first line of products that MINDCURE intends to launch are three types of organic mushroom nootropics. These products will be distributed under the following product names: MINDCURE Lion’s Mane Focus, MINDCURE Reishi Energy, and MINDCURE Turkey Tail Immunity. Each of these products will be available in powdered and capsule form.
MINDCURE is evaluating the legal and commercial viability of psychedelic compounds, such as psilocybin, as part of its future product candidates.
The process will comply with regulatory certifications and licensing within Canadian federal regulatory agencies (including Health Canada) and the US Federal regulatory agencies (including the FDA).
https://mindcure.com/our-focus/
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM